ADVERTISEMENT

Organigram gross revenue up 73% year-on-year

Beena Goldenberg, CEO of Organigram Global, joins BNN Bloomberg to discuss the company's acquisition of Motif as their outlook for the future.

Pot stocks jump as Trump signals possible reclassification

Shares of pot companies jumped on Monday after U.S. President Donald Trump said his administration is looking at reclassifying marijuana as a less dangerous drug, potentially easing criminal penalties and reshaping the industry’s federal standing.

Expect profitable growth in 2026: Aurora Cannabis CEO

Miguel Martin, CEO of Aurora Cannabis, joins BNN Bloomberg to discuss the company's Q1 earnings.

N.B. cannabis producer rebrands, seeks larger international market

One of the largest cannabis players in Canada keeps growing and growing.

Big Alcohol prepares to fight back as buzzy cannabis drinks steal sales

Top alcohol makers have been sitting on the sidelines of a cannabis beverage boom, watching brands make deals with beer and booze distributors.

Ex-Mountie sentenced for ‘reckless’ cannabis business securities violations in B.C.

The British Columbia provincial court has handed a retired RCMP officer a suspended sentence, saying the man was “reckless” but not deceitful when he convinced a neighbour to invest in his failing cannabis company.

Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble

The head of Aurora Cannabis says he’s pleased with the state of the company’s balance sheet and its performance in the most recent quarter despite a sharp selloff of its shares on Wednesday.

Aurora Cannabis reduces Q4 net loss

Miguel Martin, chief executive officer of Aurora Cannabis, joins BNN Bloomberg to discuss the company's Q4 earnings.

Organigram has sights set on global expansion after ‘record’ quarter

The head of Organigram Global Inc. says the Canadian cannabis company is looking for opportunities to expand its business to new markets after the firm beat revenue expectations in its second fiscal quarter.

Cannabis company Tilray Brands proposes a reverse stock split

Cannabis company Tilray Brands Inc. is proposing a reverse stock split for its shares.

MediPharm Labs sells facility in Hope, B.C., to Rubicon Organics for $4.5M

MediPharm Labs Corp. has signed a deal to sell its facility in Hope, B.C., to Rubicon Organics Inc. for $4.5 million in cash.

Cannabis company Aphria reaches agreement to settle shareholder class-action lawsuit

Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company made misrepresentations to capital markets in 2018.

Canopy Growth reports $121.9M Q3 loss compared with $216.8M loss a year earlier

Canopy Growth Corp. reported a loss of $121.9 million in its latest quarter compared with a loss of $216.8 million in the same quarter a year earlier.

‘I like what we’re doing,’ Tilray CEO says despite Q2 earnings miss

The head of Tilray Brands Inc. says he was pleased with the company’s performance in its latest quarter despite tax challenges in the Canadian cannabis market and legalization hurdles in the U.S.

Stephen Takacsy’s Top Picks for December 11, 2024

Top picks from Stephen Takacsy, president and CEO, and chief investment officer of Lester Asset Management